IDEAS home Printed from https://ideas.repec.org/p/mpg/wpaper/2008_3.html
   My bibliography  Save this paper

Pharmaceutical research in Wilhelmine Germany: The case of E. Merck

Author

Listed:
  • Carsten Burhop

    () (Max Planck Institute for Research on Collective Goods, Bonn)

Abstract

In this paper, we describe the emergence and evolution of pharmaceutical research at the German company E. Merck during the late 19th and early 20th century. Revolutionary changes in the scientific knowledge base, especially the rise of bacteriological research, and the market entry of dyestuff producers into pharmaceuticals made the re-organisation of pharmaceutical research during the 1890s a necessary corporate strategy. Consequently, Merck restructured its in-house research between 1895 and 1898. Moreover, the firm deepened its co-operation with universities and other outside inventors. Jointly and severally, the firm depended on outside inventors for the generation of new products, whereas in-house scientists improved the productive efficiency. Moreover, we show that a significant number of new products were launched between the late 1890s and 1905. During the following years, however, resource constraints restricted Merck’s innovative capacity.

Suggested Citation

  • Carsten Burhop, 2008. "Pharmaceutical research in Wilhelmine Germany: The case of E. Merck," Discussion Paper Series of the Max Planck Institute for Research on Collective Goods 2008_03, Max Planck Institute for Research on Collective Goods.
  • Handle: RePEc:mpg:wpaper:2008_3
    as

    Download full text from publisher

    File URL: http://www.coll.mpg.de/pdf_dat/2008_03online.pdf
    Download Restriction: no

    More about this item

    Keywords

    Business history; pharmaceutical research; case study;

    JEL classification:

    • N83 - Economic History - - Micro-Business History - - - Europe: Pre-1913
    • O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:mpg:wpaper:2008_3. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Marc Martin). General contact details of provider: http://edirc.repec.org/data/mppggde.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.